Led · Equity · Sep 2022

InHome Therapy delivers physical, occupational, and speech therapy through a Home Therapy as a Service (HTaaS) model for home health provider agencies. The company employs hundreds of therapists and has completed over 2 million patient visits in key locations across the U.S. It has scaled rapidly amid rising demand, reporting a triple-digit increase in its therapist network and business staff. Year to date, InHome Therapy completed five acquisitions and launched operations in Orlando and Houston, securing contracts with more than 40 new home health agencies. The company positions itself as an employer of choice for therapists, offering proprietary processes, education, flexibility, culture, and tools. It intends to use new capital to expand its geographic reach, pursue additional strategic acquisitions, and continue technology development.

Led · Equity · Aug 2022

CareConnectMD (CCMD) delivers comprehensive primary care, palliative care, geriatric behavioral services and 24/7 on-call support to high‑needs Medicare patients in their homes and in skilled nursing and long‑term care facilities. The company contracts with managed care and insurance plans and partners with other primary care physician groups to enable participation in value‑based care through its high‑needs Direct Contracting Entity (DCE). CCMD is one of only eight high‑needs DCEs selected by CMS to participate in the first performance of the Global and Professional Direct Contracting Model (rebranded ACO REACH). The company also offers telemedicine and emphasizes care coordination to improve outcomes and reduce costs for medically complex patients. Financially, CCMD announced the close of a $25 million financing led by TT Capital Partners to fund growth and platform enhancements. Management plans to use the proceeds to deepen presence in California, Ohio and Texas, expand into other U.S. markets, and enhance its technology platform to scale and streamline care delivery.

Led · Equity · Mar 2022

Led by CEO Leah Sparks, Wildflower Health builds digital and value-based care solutions for obstetric providers and payers. Its platform helps providers evaluate and design value-based care (VBC) models, install digital health and point-of-care decision-support tools, and adapt workflows to VBC requirements. The company continuously processes clinical and financial data to surface real-time clinical metrics and to manage payments, reconciliations, and outcomes measurement. Its proprietary maternity bundle spans prenatal to postnatal care and accounts for the total cost of pregnancy for both mother and baby. Wildflower plans to use new funding to strengthen its internal team and to prepare for nationwide expansion of that maternity bundle. Providence has increased its financial commitment and expanded a contract to install Wildflower’s solution across Southern California. Wildflower Health is a San Francisco-based mobile health software company that connects families to health resources on their smartphones. Its tools promote healthy pregnancies, track family health, and support the growth of each family member based on individual health needs over time. The company launched its Family Health platform, an integrated application to manage pregnancy and family health. Over the past year it tripled its recurring license revenue and expanded its user base by more than 10x. Led by founder and CEO Leah Sparks, Wildflower plans to use new funding to continue organizational growth and expand its Family Health platform. Wildflower Health builds Due Date Plus, a mobile maternity program that functions as a patient-navigation tool configurable by health plans to show coverage details and in‑network providers. The app is HIPAA‑compliant and is used by payers including Aetna, LifeMap and state Medicaid programs such as Wyoming’s. The company plans to broaden its product portfolio into pediatrics and family health and will launch a Spanish version of Due Date Plus in the coming months. Wildflower also agreed to a strategic partnership with Everyday Health, operator of the What to Expect franchise that reaches about 75% of pregnant women in the U.S. The new funding will support strategic expansion and ongoing product development. Wildflower Health offers Due Date Plus, a mobile maternity program available on iOS and Android that uses self-reported data to identify high-risk pregnancies and drive interventions. The app delivers customized tools and content and refers users to care management programs. The company plans to expand its mobile health offering to health plans, self-insured employers and Medicaid clients using the new funding. Wildflower was founded in 2012 by CEO Leah Sparks and Kathy Bellevin. Prior to this round the company secured seed funding in late 2012 through Rock Health.

Led · Series B · May 2021

SymphonyRM is a Palo Alto-based provider of AI-powered patient engagement solutions for health systems. Its platform helps health systems acquire, engage, and retain patients by generating data-driven, prioritized next-best-actions for every consumer, prospect, and provider. Those insights enable organizations to anticipate member needs and use proactive outreach to build deeper customer relationships, drive outcomes, and increase revenue. The company plans to use new funding to accelerate sales and marketing efforts and to increase its reach and presence in the payer segment. SymphonyRM is led by CEO Michael Linnert. It raised $25M in a Series B financing to support these initiatives.

Led · Series D · Sep 2019

Navigating Cancer offers an end-to-end oncology patient relationship management (PRM) platform adopted by more than 1,700 cancer care providers that connects providers and patients throughout the care cycle. The platform enables messaging, medication reminders, symptom reporting via a mobile app, and helps providers triage needs, manage symptoms, and streamline care coordination. Navigating Cancer’s software is used to increase patient engagement, improve patient experience, support value-based care, and help contain escalating costs. The company is on pace to grow its oncology customer base by 40% this year, reflecting accelerated adoption of its platform. Going forward, the company plans to enhance its mobile experience for oncology patients and develop AI-based population care capabilities to assess patient risk and identify proactive interventions. The PRM product roadmap emphasizes patient-reported outcomes, population care, and broader innovation to further improve outcomes and satisfaction. Navigating Cancer is a patient care and engagement company based in Seattle, Washington, led by CEO and co-founder Gena Cook. It provides a web-based hub that operates with any electronic health record vendor, enabling patients to stay informed and engaged in their care across multiple clinics, caregivers and geographies. The platform is deployed in partnership with cancer programs nationwide. In August 2015 the company closed a $10M funding round led by Merck Global Health Innovation Fund, with participation from ORIX Healthcare Capital and existing investor Rustic Canyon Partners. The company said it will use the proceeds to accelerate expansion of the business. No revenue or user metrics were disclosed in the article. Navigating Cancer provides an online patient portal and interactive community aimed at helping cancer patients prepare for visits, complete paperwork, manage treatment organization, and track symptoms. The company says its platform is already used by more than 500 oncology providers and is supported by a 14-person team. Management is led by co‑founder and CEO Gena Cook, with co‑founder Michael Graff heading product/technical work; their backgrounds include McKesson, Bristol‑Myers Squibb, Ancestry.com and Microsoft. Product roadmaps cited in the article include hiring additional developers, expanding portal features, and integrating electronic access to health information by connecting with EMR vendors to make release of information seamless and useful for patients. The article frames this work against a large market opportunity—National Cancer Institute estimates cited for people with current or prior cancer and annual new cases—and notes competing patient‑focused sites such as MyHealthTeams, PatientsLikeMe, Avva Health and Onc Charts. Financially, the company has raised multiple rounds and is investing proceeds into product development and EMR integrations.